Qube Research & Technologies Ltd
- SEC CIK
- 0001729829
- Latest filing
- Aug 14, 2026
SPRY holding history
ARS Pharmaceuticals, Inc. in every 13F filed by Qube Research & Technologies Ltd, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
SPRY overviewAll 13F holders of SPRYFull Q2 2026 holdings
- Shares (Q4 2025)
- 0
- Sold out in Q4 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 8
- Since Q2 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2025 | 0 | $0 | 0.0% | −1,034,798−100.0% | Sold out | Holders |
| Q3 2025 | 1,034,798 | $10.4M | <0.1% | +1,034,798 | New | Holders |
| Q1 2025 | 0 | $0 | 0.0% | −130,289−100.0% | Sold out | Holders |
| Q4 2024 | 130,289 | $1.37M | <0.1% | +90,593+228.2% | Added | Holders |
| Q3 2024 | 39,696 | $575.6K | <0.1% | +39,696 | New | Holders |
| Q2 2024 | 0 | $0 | 0.0% | −12,633−100.0% | Sold out | Holders |
| Q1 2024 | 12,633 | $129.1K | <0.1% | +12,633 | New | Holders |
| Q2 2023 | 0 | $0 | 0.0% | −77,369−100.0% | Sold out | Holders |
| Q1 2023 | 77,369 | $503.7K | <0.1% | +48,532+168.3% | Added | Holders |
| Q4 2022 | 28,837 | $246.0K | <0.1% | +12,412+75.6% | Added | Holders |
| Q3 2022 | 16,425 | $87.0K | <0.1% | −1,441−8.1% | Reduced | Holders |
| Q2 2022 | 17,866 | $76.0K | <0.1% | +17,866 | New | Holders |